(PRWEB) February 11, 2014 <\/p>\n
The report Autologous Cell Therapy (ACT) Market (2012 - 2017), would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential market size; it also identifies driving and restraining factors for the global ACT market with analysis of trends, opportunities and challenges. The market is segmented and revenue is forecasted on the basis of major regions such as USA, Europe and Rest of the World (ROW). Further, market is segmented and revenues are forecasted on the basis of potential application areas of ACT. <\/p>\n
Browse ACT market research data tables\/figures spread through 111 slides and in-depth TOC on Autologous Cell Therapy Market\". http:\/\/www.marketsandmarkets.com\/Market-Reports\/autologous-cell-therapy-market-837.html<\/a> <\/p>\n Early buyers will receive 10% customization on this report @ http:\/\/www.marketsandmarkets.com\/requestCustomization.asp?id=837<\/a>. <\/p>\n The global market for ACT is valued around $650 million by 2011 with a CAGR of 21%. Several products and technologies of ACT are in pipeline which is expected to hit the market during the forecast period, which will result in increased growth rate. <\/p>\n There is a wide market potential and favorable landscape for adoption across many geographical locations of the world. During the forecast period, these technologies are expected to revolutionize the area of bio-pharma and personalized medicine. High incidence and lack of effective treatment for several diseases will drive the ACT technology in developed and developing nations. <\/p>\n Investment activities, for the past five years are actively held in research and developments, attracting interests of cell therapy industry firms, medical centers and academic institutions. ACT potential can be demonstrated by mergers, collaborations, acquisitions and partnerships that happened actively between the ACT technology developing companies in past three years. Development of sophisticated automation devices for cell expansion and culture process for use in the treatment is one of the emerging trends of ACT market. <\/p>\n Autologous Stem Cell and Non-Stem Cell Based treatments in North America are rapidly emerging as a major treatment for various incurable diseases such as Myocardial infarction, ischemic heart failure and diabetes. <\/p>\n Browse Related Reports: Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 2017) http:\/\/www.marketsandmarkets.com\/Market-Reports\/transfection-technologies-market-895.html<\/a> <\/p>\n High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018 http:\/\/www.marketsandmarkets.com\/Market-Reports\/high-throughput-screening-market-134981950.html<\/a> <\/p>\n <\/p>\n See the original post here: <\/p>\n Autologous Stem Cell and Non-Stem Cell Based Therapies Market Worth $2.2 Billion by 2017<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" (PRWEB) February 11, 2014 The report Autologous Cell Therapy (ACT) Market (2012 - 2017), would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential market size; it also identifies driving and restraining factors for the global ACT market with analysis of trends, opportunities and challenges. The market is segmented and revenue is forecasted on the basis of major regions such as USA, Europe and Rest of the World (ROW). Continue reading